NADAC acquisition cost data for ALBUTEROL HFA 90 MCG INHALER. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 66993001968 | $1.86 | 2022-12-21 | Rx |
| 00093317431 | $2.97 | 2022-12-21 | Rx |
| 45802008801 | $2.97 | 2022-12-21 | Rx |
| 68180096301 | $2.97 | 2022-12-21 | Rx |
| 00054074287 | $3.23 | 2022-12-21 | Rx |
| 00254100752 | $3.23 | 2022-12-21 | Rx |
| 00781729685 | $3.23 | 2022-12-21 | Rx |
| 69097014260 | $3.23 | 2022-12-21 | Rx |
| 72572001401 | $3.23 | 2022-12-21 | Rx |
| 76282067942 | $3.23 | 2022-12-21 | Rx |
Generic: Albuterol Sulfate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $177.4M | 3,065,577 | 1,512,149 | $3.65 |
| 2020 | $474.5M | 8,571,559 | 3,668,634 | $3.80 |
| 2021 | $634.9M | 12,419,551 | 4,847,424 | $3.85 |
| 2022 | $710.0M | 15,028,182 | 5,656,896 | $3.74 |
| 2023 | $583.9M | 16,614,957 | 6,126,707 | $2.80 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.